Onderneming CannaPharmaRX, Inc. Other OTC
Aandelen
CPMD
US13765D1090
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dean Medwid
CEO | Chief Executive Officer | - | 01-06-23 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 01-01-17 |
Oliver Foeste
DFI | Director of Finance/CFO | 48 | 13-10-23 |
John Cassels
AUD | Comptroller/Controller/Auditor | 75 | 23-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rick Orman
BRD | Director/Board Member | 74 | 23-04-19 |
Dominick Colvin
CEO | Chief Executive Officer | 55 | 01-01-17 |
Anthony Panek
BRD | Director/Board Member | 39 | 25-08-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 2 455 000 | 0 | 0 | 98,62 % |
Aandeel B | 1 | 668 732 166 | 659 614 589 ( 98,64 %) | 6 230 761 ( 0,9317 %) | |
Aandeel C | 0 | 84 416 | 0 | 0 |
Bedrijfsgegevens
CannaPharmaRx, Inc.
888 3rd Street South West Suite 3600
T2P 5C5, Calgary
+
http://www.cannapharmarx.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,59% | 727 mld. | |
-7,89% | 347 mld. | |
+15,66% | 319 mld. | |
+0,24% | 274 mld. | |
+13,47% | 238 mld. | |
+7,35% | 204 mld. | |
-6,42% | 203 mld. | |
+4,23% | 161 mld. | |
-1,70% | 160 mld. |